Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Longeveron Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +9 vs. Q1 2024
- Shares held
- 331.3K
- +281.5K (+565.6%) vs. Q1 2024
- Total value
- $534.1K
- +$372.3K (+230.2%) vs. Q1 2024
- New holders
- 12
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 53 | $0 | 0.00% | +43+430.0% | Added |
| UBS Group AG | 1 | $2 | 0.00% | −11−91.7% | Reduced |
| FMR LLC | 1 | $2 | 0.00% | +1 | New |
| LGT Financial Advisors LLC | 36 | $58 | 0.00% | +1+2.9% | Added |
| Naples Money Management LLC | 100 | $157 | 0.00% | +100 | New |
| Qube Research & Technologies Ltd | 100 | $161 | 0.00% | +100 | New |
| The PNC Financial Services Group, Inc. | 297 | $478 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 464 | $747 | 0.00% | −7−1.5% | Reduced |
| EverSource Wealth Advisors, LLC | 481 | $1.51K | 0.00% | +481 | New |
| Morgan Stanley | 1,409 | $2.27K | 0.00% | +1,400+15,555.6% | Added |
| Bank of America Corp | 1,682 | $2.71K | 0.00% | +1,682 | New |
| Tower Research Capital LLC (TRC) | 4,899 | $7.89K | 0.00% | +2,304+88.8% | Added |
| Vontobel Holding Ltd. | 10,000 | $16.1K | 0.00% | +10,000 | New |
| BlackRock Inc. | 10,016 | $16.1K | 0.00% | −1,125−10.1% | Reduced |
| Creative Planning | 11,200 | $18.0K | 0.00% | +267+2.4% | Added |
| Squarepoint Ops LLC | 17,831 | $28.7K | 0.00% | +17,831 | New |
| Citadel Advisors LLC | 22,485 | $36.2K | 0.00% | +22,485 | New |
| Capital Investment Advisory Services, LLC | 26,525 | $42.7K | 0.00% | +26,525 | New |
| Geode Capital Management, LLC | 30,994 | $49.9K | 0.00% | +30,994 | New |
| Two Sigma Investments, LP | 46,041 | $74.1K | 0.00% | +46,041 | New |
| Renaissance Technologies LLC | 146,700 | $236.2K | 0.00% | +146,700 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −24,132−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |